Review: β-blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction

January 2003
ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p4
Academic Journal
Focuses on a study that examined the role of β-blockers in increasing fatigue and sexual dysfunction and depression after myocardial infarction. Data sources; Characteristics of patients from which data were extracted; Conclusions.


Related Articles

  • Tips from Other Journals. Wellbery, Caroline; Miller, Karl E.; Walling, Anne D. // American Family Physician;7/15/2007, Vol. 76 Issue 2, p283 

    The article presents several studies on different medical conditions. The authors' findings revealed that there is no conclusion that can be made with operative versus nonoperative approach in treating back pain. Another study indicated that there is no significant differences in the presence of...

  • Study: Long-Term Use of Clopidogrel for DES Patients.  // Clinical Oncology Alert;Jan2007, Vol. 23 Issue 1, Special section p1 

    The article covers issues related to pharmacology. It cites that patients with coronary artery disease who have been given intra-coronary, drug-eluding stents (DES) may benefit from long-term use of clopidogrel. A study in the "Annals of Internal Medicine" states that patients tend to...

  • Beta-Blockers and Depression -- Unlinked? Elliott, William T. // Clinical Oncology Alert;Jan2007 Pharmacology Watch, p2 

    The article discusses findings of a study which examined the possible risk of beta-blockers following myocardial infarction. The risk being studied is depression. The study revealed that there were no differences between beta-blocker and non-beta-blocker users regarding the presence of...

  • Beta--Blockers after Myocardial Infarction: Influence of First--Year Clinical Course on Long--Term Effectiveness. Viscoli, Catherine M.; Horwitz, Ralph I.; Singer, Burton H. // Annals of Internal Medicine;1/15/93, Vol. 118 Issue 2, p99 

    Presents a study that examined the influence of first year clinical course on the long-term effectiveness of the beta-blocker propranolol after myocardial infarction. Assessment of the mortality rates; Analysis of changes in the treatment of patients; Evaluation of the effectiveness of...

  • Post-MI therapy: Low-dose beta blockers may be as good as, maybe better than, high-dose.  // Geriatrics;Jun98, Vol. 53 Issue 6, p98 

    Presents a summary of the article `Beta-blocker dosages and mortality after myocardial infarction: Data from a large health maintenance organization,' by H.V. Barron, S. Viskin, R.J. Lundstrom and others, published in the March 9, 1998 issue of the `Archives of Internal Medicine' periodical.

  • Should every survivor of a heat attack be given a beta-blocker? Hampton, J.R.; Breckenridge, A.; Rose, Geoffrey // British Medical Journal (Clinical Research Edition);7/3/1982, Vol. 285 Issue 6334, p33 

    Part I, II and III. Focuses on the use of a beta-blocker in survivor of heart attack in Great Britain. Difficulty to use beta-blockers in the initial stages of a heart attack; Reduction of mortality in patients treated with beta-blockers; Administration of beta-blockers in patients due to...

  • Confidence in results of beta-blocker postinfarction trials. Baber, N.S.; Lewis, J.A. // British Medical Journal (Clinical Research Edition);6/12/1982, Vol. 284 Issue 6331, p1749 

    Examines the results of beta-blockers in myocardial infarctions. Reduction of mortality; Temporal distribution of trial admission; Improvements of technique for calculating confidence limits.

  • Half of MI patients don't get beta blockers; those who don't get enough.  // Modern Medicine;Sep95, Vol. 63 Issue 9, p38 

    Presents an abstract of the report `Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice,' by S. Viskin et. al. published on the May 1995 issue of `Journal of American College of Cardiology'.

  • Drugs for elderly are not always used wisely.  // HealthFacts;Feb97, Vol. 22 Issue 2, p3 

    Reports about the under-prescription of beta-blocker drugs for the elderly who survived a heart attack. Heavy promotion of calcium channel blockers by drug companies to doctors; Association of calcium channel blockers with doubled risk of death; Percentage of patients in the study who received...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics